Press release
06.12.2022 To the attention of interested persons ETF statement on the use of the EMA approved bivalent original/Omicron BA.4-5 mRNA […]
Important notification
06.12.2022 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders We hereby inform you that on 1 […]
Important notification
06.12.2022 To the attention of in vitro diagnostics laboratories in Romania and all stakeholders Please be advised that on 30 […]
Press release
02.12.2022 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November – 1 […]
Press release
02.12.2022 To the attention of interested persons EMA recommends withdrawal of pholcodine medicines from EU market download document …
Press release
30.11.2022 To the attention of interested persons Status update: Implementation of the Clinical Trials Regulation download document …
Important notification
23.11.2022 To the attention of economic operators and all stakeholders Please be informed that, starting from 22 November 2022, the […]
Press release
11.11.2022 To the attention of interested persons EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors […]
Press release
11.11.2022 To the attention of interested persons EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines download document …
Press release
10.11.2022 To the attention of interested persons EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine download […]